Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
Huey RW, Shah AT, Reddi HV, Dasari P, Topham JT, Hwang H, Dhillon N, Willett A, Smaglo BG, Estrella JS, Rashid A, Matamoros A, Overman MJ, Choquette L, Omerza G, Kelly K, Wang X, Loree JM, Rueter J, Varadhachary GR, Raghav K. Huey RW, et al. Among authors: kelly k. J Natl Cancer Inst. 2023 Aug 8;115(8):994-997. doi: 10.1093/jnci/djad095. J Natl Cancer Inst. 2023. PMID: 37202363 Free PMC article. Clinical Trial.
Molecular profiling of CNS tumors for the treatment and management of disease.
Nie Q, Hsiao MC, Chandok H, Rowe S, Prego M, Meyers B, Omerza G, Hesse A, Uvalic J, Soucy M, Bergeron D, Peracchio M, Burns S, Kelly K, Rueter J, Reddi HV. Nie Q, et al. Among authors: kelly k. J Clin Neurosci. 2020 Jan;71:311-315. doi: 10.1016/j.jocn.2019.11.035. Epub 2019 Dec 16. J Clin Neurosci. 2020. PMID: 31859178
Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants.
Nie Q, Omerza G, Chandok H, Prego M, Hsiao MC, Meyers B, Hesse A, Uvalic J, Soucy M, Bergeron D, Peracchio M, Burns S, Kelly K, Rowe S, Rueter J, Reddi HV. Nie Q, et al. Among authors: kelly k. Cancer Genet. 2020 Apr;242:25-34. doi: 10.1016/j.cancergen.2019.11.008. Epub 2020 Jan 14. Cancer Genet. 2020. PMID: 31992506
Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease.
Hesse AN, Fabricius W, Thomas CA, Gaindh R, Christman R, Selvam P, Prego M, Lewis G, Uvalic J, Bergeron D, Burns S, Sisson B, Kelly K, Rueter J, Reddi HV. Hesse AN, et al. Among authors: kelly k. Case Rep Oncol. 2018 Mar 27;11(1):196-205. doi: 10.1159/000487882. eCollection 2018 Jan-Apr. Case Rep Oncol. 2018. PMID: 29681821 Free PMC article.
Novel CTNND2-TERT fusion in a spindle cell liposarcoma.
Occidental M, Shen G, Feng X, Zhu K, Kelly K, Nie Q, Reddi HV, Lakiotaki E, Viniou NA, Korkolopoulou P, Linos K, Jour G. Occidental M, et al. Among authors: kelly k. Genes Chromosomes Cancer. 2020 Sep;59(9):544-548. doi: 10.1002/gcc.22856. Epub 2020 May 6. Genes Chromosomes Cancer. 2020. PMID: 32352179
Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay.
Selvam P, Hsiao MC, Omerza G, Bergeron D, Rowe S, Uvalic J, Soucy M, Peracchio M, Burns S, Meyers B, Prego M, Nie Q, Ananda G, Chandok H, Kelly K, Hesse A, Reddi HV. Selvam P, et al. Among authors: kelly k. Mol Diagn Ther. 2020 Feb;24(1):103-111. doi: 10.1007/s40291-019-00435-9. Mol Diagn Ther. 2020. PMID: 31754995
3,728 results